Fractionated radioimmunotherapy with I-131-labeled chimeric antibody G250 (cG250) in patients with metastatic renal cell carcinoma.

被引：0
|
作者：
Divgi, CR
O'Donoghue, JA
McGagh, DA
Motzer, RJ
Anwar, K
Sheikh, A
Gonzalez, RS
Welt, S
Old, LJ
Larson, SM
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Ludwig Inst Canc Res, New York, NY USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 1999年 / 40卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
970
引用
收藏
页码：217P / 217P
页数：1
相关论文
共 50 条
  • [41] ImmunoPET Imaging of Renal Cell Carcinoma with 124I- and 89Zr-Labeled Anti-CAIX Monoclonal Antibody cG250 in Mice
    Stillebroer, Alexander B.
    Franssen, Gerben M.
    Mulders, Peter F. A.
    Oyen, Wim J. G.
    van Dongen, Guus A. M. S.
    Laverman, Peter
    Oosterwijk, Egbert
    Boerman, Otto C.
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2013, 28 (07) : 510 - 515
  • [42] Anti-renal cell carcinoma chimeric antibody G250: cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity
    Zhanqi Liu
    Fiona E. Smyth
    Christoph Renner
    Fook-Thean Lee
    Egbert Oosterwijk
    Andrew M. Scott
    [J]. Cancer Immunology, Immunotherapy, 2002, 51 : 171 - 177
  • [43] Pharmacokinetic model of Iodine-131-G250 antibody in renal cell carcinoma patients
    Loh, A
    Sgouros, G
    O'Donoghue, JA
    Deland, D
    Puri, D
    Capitelli, P
    Humm, JL
    Larson, SM
    Old, LJ
    Divgi, CR
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (03) : 484 - 489
  • [44] A Prospective Open-label Single-Arm Phase II Study of chimeric monoclonal antibody cG250 in advanced renal cell carcinoma patients
    Varga, Z
    de Mulder, P
    Kruit, W
    Hegele, A
    Hofmann, R
    Lamers, C
    Warnaar, S
    Mala, C
    Ullrich, S
    Mulders, P
    [J]. FOLIA BIOLOGICA, 2003, 49 (02) : 74 - 77
  • [45] Comparison of 131I-CG250 monoclonal antibody immunoscintigraphy (RIS) and FDG-PET imaging in patients with metastatic renal cell carcinoma (RCC).
    Brouwers, AH
    Dörr, U
    Bihl, H
    Steffens, MG
    Oyen, WJ
    Boerman, OC
    Oosterwijk, E
    Corstens, FH
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 117P - 117P
  • [46] Generation of chimeric bispecific G250/anti-CD3 monoclonal antibody, a tool to combat renal cell carcinoma
    Luiten, RM
    Coney, LR
    Fleuren, GJ
    Warnaar, SO
    Litvinov, SV
    [J]. BRITISH JOURNAL OF CANCER, 1996, 74 (05) : 735 - 744
  • [47] Application of Monoclonal Antibody G250 Recognizing Carbonic Anhydrase IX in Renal Cell Carcinoma
    Oosterwijk-Wakka, Jeannette C.
    Boerman, Otto C.
    Mulders, Peter F. A.
    Oosterwijk, Egbert
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (06) : 11402 - 11423
  • [48] Effect of tyrosine kinase inhibitor treatment of renal cell carcinoma on the accumulation of carbonic anhydrase IX-specific chimeric monoclonal antibody cG250
    Oosterwijk-Wakka, Jeannette C.
    Kats-Ugurlu, Gursah
    Leenders, William P. J.
    Kiemeney, Lambertus A. L. M.
    Old, Lloyd J.
    Mulders, Peter F. A.
    Oosterwijk, Egbert
    [J]. BJU INTERNATIONAL, 2011, 107 (01) : 118 - 125
  • [49] LUD01-014: Phase 1/2 study of chimeric monoclonal antibody cG250 in combination with vinblastine in patients with advanced renal cell carcinoma (ARCC).
    Al-Batran, SE
    Neumann, A
    Atmaca, A
    Ruppert, M
    Karbach, J
    Ritter, G
    Hoffman, E
    Old, L
    Knuth, A
    Jaeger, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 170S - 170S
  • [50] Radioimmunotherapy with 131I-cG250 monoclonal antibody in patients with metastasized RCC, a phase I/II study.
    Steffens, MG
    Boerman, OC
    Oyen, WJG
    De Mulder, PHM
    Witjes, JA
    Oosterhof, GON
    Corstens, FHM
    Debruyne, FMJ
    Oosterwijk, E
    [J]. JOURNAL OF UROLOGY, 1998, 159 (05): : 148 - 148
12345